TrialResults - center   -  Clinical trials results database in cardiology oncology (not yet available) neurology (not yet available)

You are here:  Home > Search and browse > Browse pathologie > Directory by pathology

Cardiovascular prevention clinical trials - Results and meta-analysis

Randomized clinical trials are available for the following class of treatment and clinical condition (type of patients).

Cardiovascular prevention  

cholesterol lowering intervention:

- patients with LDL elevation and without CHD    pdf

- diabetic patients    pdf

- elderly    pdf

- high risk patients with or without LDL cholesterol elevation    pdf

- patients with prior MI or with CHD    pdf

- patients with other atherosclerotic localisation    pdf

- patient with related disease    pdf

- all chronical situations    pdf

- post stroke (or TIA)    pdf

- primary prevention    pdf

- patients with renal insufficiency (on hemodialysis or transplant)    pdf

- women    pdf

antithrombotics:

- patienst at high risk    pdf

- all type of patients    pdf

- diabetic patients    pdf

- primary prevention    pdf

omega-3 fatty acids :

- all type of patients    pdf

- patients at high risk    pdf

- pateints at low risk    pdf

- patients with an implantable cardioverter defibrillator    pdf

plasma homocysteine lowering intervention:

- all type of patients    pdf

- secondary prevention    pdf

- primary prevention    pdf

- patients with chronic kidney disease    pdf

antioxydants:

- all type of patients    pdf

- diabetic patients    pdf

- patients with renal disease    pdf

- primary prevention    pdf

- secondary prevention    pdf

antiplatelets drug:

- diabetic patients    pdf

- all type of patients    pdf

- secondary prevention in patients with intermittent claudication    pdf

- secondary prevention in patients with CAD    pdf

- primary prevention    pdf

- patients without established disease    pdf

lifestyle intervention:

- all type of patients    pdf

- primary prevention    pdf

- secondary prevention    pdf

niacin:

- all type of patients    pdf

ACAT inhibition:

- all type of patients    pdf

CEPT inhibition:

- all type of patients    pdf

polypill:

- all type of patients    pdf

weight-loss drugs:

- all type of patients    pdf

- overweight or obese patients    pdf

- diabetic patients    pdf

hormonal replacement therapy:

- all type of patients    pdf

- primary prevention    pdf

- secondary prevention    pdf

anticoagulant:

- secondary prevention    pdf

HDL increasing drugs:

- all type of patients    pdf

dietary salt reduction:

- all type of patients    pdf

- hypertensive patients    pdf

- normotensive subjects    pdf

diet:

- all type of patients    pdf

PCSK9 Inhibitors:

- all type of patients    pdf

See also:

• cholesterol lowering intervention - all trials of cholesterol lowering intervention by pathology
• antithrombotics - all trials of antithrombotics by pathology
• omega-3 fatty acids - all trials of omega-3 fatty acids by pathology
• plasma homocysteine lowering intervention - all trials of plasma homocysteine lowering intervention by pathology
• antioxydants - all trials of antioxydants by pathology
• antiplatelets drug - all trials of antiplatelets drug by pathology
• lifestyle intervention - all trials of lifestyle intervention by pathology
• niacin - all trials of niacin by pathology
• ACAT inhibition - all trials of ACAT inhibition by pathology
• CEPT inhibition - all trials of CEPT inhibition by pathology
• polypill - all trials of polypill by pathology
• weight-loss drugs - all trials of weight-loss drugs by pathology
• hormonal replacement therapy - all trials of hormonal replacement therapy by pathology
• anticoagulant - all trials of anticoagulant by pathology
• HDL increasing drugs - all trials of HDL increasing drugs by pathology
• dietary salt reduction - all trials of dietary salt reduction by pathology
• diet - all trials of diet by pathology
• PCSK9 Inhibitors - all trials of PCSK9 Inhibitors by pathology

• cholesterol lowering intervention - Access to clinical trials by treatment
• antithrombotics - Access to clinical trials by treatment
• omega-3 fatty acids - Access to clinical trials by treatment
• plasma homocysteine lowering intervention - Access to clinical trials by treatment
• antioxydants - Access to clinical trials by treatment
• antiplatelets drug - Access to clinical trials by treatment
• lifestyle intervention - Access to clinical trials by treatment
• niacin - Access to clinical trials by treatment
• ACAT inhibition - Access to clinical trials by treatment
• CEPT inhibition - Access to clinical trials by treatment
• polypill - Access to clinical trials by treatment
• weight-loss drugs - Access to clinical trials by treatment
• hormonal replacement therapy - Access to clinical trials by treatment
• anticoagulant - Access to clinical trials by treatment
• HDL increasing drugs - Access to clinical trials by treatment
• dietary salt reduction - Access to clinical trials by treatment
• diet - Access to clinical trials by treatment
• PCSK9 Inhibitors - Access to clinical trials by treatment

Entry terms:

Search Cardiovascular prevention clinical trials in Pubmed

Search Cardiovascular prevention clinical trials in ClinicalTrials.gov

Search Cardiovascular prevention clinical trials in Wikipedia

Search Cardiovascular prevention in drugs.com

browse_patho2

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar